Dimebolin Hydrochloride Dimebon
Dimebolin Hydrochloride Dimebon is a first generation antihistamine drug originally developed in Russia. Dimebolin Hydrochloride Dimebon has been available in Russia since 1983. However, Dimebolin Hydrochloride Dimebon was taken off the market when newer antihistamine drugs came onto the market.
Dimebolin Hydrochloride Dimebon is an orally-available, small-molecule agent that is in the clinical trials phase of testing for the treatment of Alzheimer's disease and Huntington's diseases.
In clinical trials for Alzheimer’s, a 20mg pill of the drug, Dimebolin Hydrochloride Dimebon taken three times a day, appears to be twice as effective in improving cognitive performance and preventing deterioration in memory as existing drugs.
Many families affected by Alzheimer’s are hoping that this newly-rediscovered medicine, Dimebolin Hydrochloride Dimebon, will prove to be a successful treatment for dementia.
Dimebolin Hydrochloride Dimebon is currently unavailable in the U.S. If you are interested in finding out when Dimebolin Hydrochloride Dimebon will be available for purchase please sign up for our Dimebolin Hydrochloride Dimebon Availability Alert service. We will make sure that you are one of the first to know when Dimebolin Hydrochloride Dimebon becomes available.